… facial lipoatrophy, we identified a population of children with significant metabolic derangements,
including dyslipidemia, hypoadiponectinemia, and impaired growth. … and an increase in …

… resistance and the associated impaired glucose tolerance and … to be associated with
diabetes, dyslipidemia, and possibly an … growth hormone was approved for use in HIV-associated …

… to improve insulin sensitivity, dyslipidemia, and glucose levels. … measured hypoleptinemia
and hypoadiponectinemia; the … The pathogenesis involves the impairment of fat deposition …

… Hypoadiponectinemia, dyslipidemia, and impaired growth in children with HIV-associated
facial lipoatrophy. J Pediatr Endocrinol Metab 2007; 20: 65-74. [28] Krause JC, Toye MP, …

… of HIV-associated lipodystrophy syndrome in children is also … development were also delayed
in the HIV-infected children … burden in children with HIV-associated dyslipidemia, their risk …

… lipodystrophy and metabolic syndrome, or more specifically and more commonly dyslipidemia
and impaired … , is defined as HIV/HAART-associated lipodystrophy syndrome (HALS) [4]. …

… circumference, hypertension, dyslipidemia and hyperglycemia, … Hypoadiponectinemia has
been reported in HIV-infected … compared with those with lipoatrophy or no lipodystrophy at all, …

… HIV-associated LD in children included body fat abnormalities, insulin resistance, and
dyslipidemia. … However, we were not able to show hypoadiponectinemia in the children with LD. …

… to treat opportunistic infections can impair testosterone levels. … hyperlipidemia and a strong
family history of hyperlipidemia … of ART, HIV-associated wasting remains a considerable …

… Zidovudine, emtricitabine and abacavir impair cell proliferation and increase lactate and
lipid production but show no mitochondrial depletion. Combinations of the drugs show that they …